Perceptive Advisors
PE / VC
1999
$9 700 M
New York City, New York, United States
Investment Ticket
Investment Horizon
Investment Stage
Exit Strategy
Profile
Perceptive is focused on supporting the progress of the life sciences industry by identifying opportunities and directing financial resources to the most promising technologies in healthcare.
The information presented in this page is included to enable professional networking by Perceptive Advisor’s employees and should not be used for any other purpose. As such, Perceptive Advisor’s use of LinkedIn is not an offer to, or solicitation of, any potential clients or investors for the provision of investment management, advisory or any other related services. No information posted by Perceptive Advisors should be construed as investment advice, or as an offer to sell, or a solicitation of an offer to buy, any security or other instrument.
Industry
Region of investment
Perceptive Advisors Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
Perceptive Xontogeny Venture Fund II, LP
|
Venture Capital (VC)
|
Biotechnology
Healthcare Services
|
Pre-seed
Seed
Series A
|
North America
South America
Europe
Middle East
Africa
Asia
Australia and others
|
$5-10 m
|
$515 M
|
May 2021
|
|
Perceptive Credit Opportunities Fund III
|
Venture Capital (VC)
|
Biotechnology
Healthcare Services
|
Pre-seed
Seed
Series A
|
North America
South America
Europe
Middle East
Africa
Asia
Australia and others
|
$5-10 m
|
$1000 M
|
December 2020
|
|
Perceptive Xontogeny Venture Fund
|
Venture Capital (VC)
|
Biotechnology
Healthcare Services
|
Pre-seed
Seed
Series A
|
North America
South America
Europe
Middle East
Africa
Asia
Australia and others
|
$5-10 m
|
$210 M
|
December 2019
|
